FDA — authorised 23 September 1993
- Marketing authorisation holder: ALCON
- Status: approved
🇺🇸 Alomide in United States
FDA authorised Alomide on 23 September 1993
Marketing authorisations
FDA — authorised 23 September 1993
- Application: NDA020191
- Marketing authorisation holder: NOVARTIS
- Local brand name: ALOMIDE
- Indication: SOLUTION/DROPS — OPHTHALMIC
- Status: approved
Alomide in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Rare Disease approved in United States
Frequently asked questions
Is Alomide approved in United States?
Yes. FDA authorised it on 23 September 1993; FDA authorised it on 23 September 1993.
Who is the marketing authorisation holder for Alomide in United States?
ALCON holds the US marketing authorisation.